Growth Opportunities in the Global Hospital-at-home Platforms and Services Industry, Forecast to 2029

Healthcare Growth Opportunities in the Global Hospital-at-home Platforms and Services Industry, Forecast to 2029

In-hospital Care Challenges and Promising Hospital-at-home Outcomes Will Spur Future Growth Potential

INDUSTRY
Healthcare
SECTOR
Life Sciences

RELEASE DATE
10-May-2024
REGION
Global
DELIVERABLE TYPE
Market Research

RESEARCH CODE
K9D0-01-00-00-00
SKU
HC_2024_718
Yes
SHARE

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC_2024_718

Growth Opportunities in the Global Hospital-at-home Platforms and Services Industry, Forecast to 2029
Published on: 10-May-2024 | SKU: HC_2024_718

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

The hospital-at-home (HaH) care model provides hospital-grade care in a home setting for acute patients with conditions ranging from asthma and pneumonia to congestive heart failure. This analysis will cover market size and forecast at the solution level, including technological solutions and care coordination services for acute care management HaH implementation. The geographic coverage is global, and the study period is from 2023 to 2029, while the forecast period extends from 2024 to 2029. Frost & Sullivan has identified three growth opportunities for industry stakeholders to seize.

This business model promises to help hospitals and health systems in general overcome workforce shortages and capacity issues. Studies and evaluations demonstrate that the HaH’s outcomes are equivalent to or on par with in-hospital care, garnering attention from all stakeholders. Other improvement parameters include reductions in costs, hospital readmission rates, risks of hospital-acquired infections, bed capacity, operational efficiency, and patient recovery time. HaH is, therefore, a viable alternative for healthcare players to provide quality care outside of the hospital setting.

Author: Sagar Thamaji Mukhekar

Revenue Forecast

The revenue estimate for the base year 2023 is $8,952.7 million, with a CAGR of 19.5% for the study period from 2023 to 2029.

Revenue Forecast

 

The Impact of the Top 3 Strategic Imperatives on the Hospital-at-home Industry

Internal Challenges

  • Why:
    • Challenges to providers due to workforce shortages and capacity expansion have intensified.
    • Providers struggle to address the growing healthcare demand and find it challenging to build additional infrastructure capacity due to costs.
  • Frost Perspective:
    • The hospital-at-home (HaH) model will play a pivotal role in overcoming providers’ pressing challenges related to workforce and capacity.
    • Providers will consider the HaH model to be a viable alternative because it shifts the care burden from hospitals to homes, virtually increasing capacity in hospitals.

Customer Value Chain Compression

  • Why:
    • New care models outside of hospital settings can use limited hospital resources more effectively to accommodate the clinical demands of aging and chronically ill populations.
    • People will gain confidence in this type of home care and prefer it, as remote patient management solutions become stronger and more reliable.
  • Frost Perspective:
    • Hospital care settings will eventually cater only to critical conditions, while other acute care activities move to the patient’s home.
    • Advanced technologies will allow treatment for more acute conditions under a HaH care model, improving patient experiences and outcomes.

Disruptive Technologies

  • Why:
    • Home care had been mostly confined to low-acuity services, but advanced remote monitoring and digital health solutions are causing a shift.
    • Home care is becoming more integrated thanks to a combination of virtual care and remote patient monitoring technology and services.
  • Frost Perspective:
    • Remote monitoring and telehealth technologies will grow highly at a 35% to 40% rate, with the major push coming from the home care segment.
    • AI, automation, and similar technologies are contributing to this change.

 

Scope of Analysis

  • Stable post-op and ICU patients can also use HaH care.
  • The US Centers for Medicare and Medicaid Services (CMS) states that, under this model, the patient’s home is considered part of the hospital during the tenure of care.
  • Hospitals can provide many services in a home setting:
    • Diagnostics such as electrocardiograms, echocardiograms, and X-rays
    • Treatments such as oxygen therapy, intravenous fluids, antibiotics, and other medicines and pharmaceuticals
    • Skilled nursing services
  • Conditions commonly treated in HaH settings include:
    • Acute pneumonia
    • Cellulitis
    • Urinary tract infection
    • Dehydration
    • Heart failure
    • Chronic obstructive pulmonary disease
    • Sepsis
    • Post-surgical care

 

Market Segmentation

Solution

  • Technology Solutions

    • Virtual Visit Solutions
      • Integrated platforms for chat and video calls
    • Remote Patient Monitoring
      • Clinical-grade wearables
      • Connected remote monitoring devices
      • Clinical dashboard for patient data
  • Coordination Services
    • Clinical Operations and Care Protocols
    • Administrative and Logistics Support
    • Coordination and Patient Eligibility
    • Home Monitoring Technology Support

Competitive Environment

Number of Competitors More than 30 with revenue greater than $1 million
Competitive Factors Cost, performance, scheduling, support, technology, reliability, contractor relationships, customer relationships
Key End-user Industry Verticals Hospitals, physician practices, integrated delivery networks, accountable care organizations
Leading Competitors Current Health, Dispatch Health, Signify Health, Medically Home, The Chartis Group
Other Notable Competitors Biofourmis, Health Recovery Solutions, Huma Health, Contessa Health, WellSky, BioIntelliSense, NTT Data
Distribution Structure Direct sales
Notable Acquisitions and Mergers CVS Health acquired Signify Health; Amedisys acquired Contessa Health

 

Key Competitors

  • Current Health
  • Biofourmis
  • Doccla
  • Huma Health
  • Vivify Health
  • Locus Health
  • Health Recovery Solutions
  • BioIntelliSense
  • Cadence
  • Reimagine Care
  • Welldsky
  • Datos Health
  • Telstra Health
  • CareMonitor
  • Vivalink
  • Conduit Health Partners
  • Medically Home
  • Dispatch Health
  • Contessa Health
  • Chartis
  • Wellsky
  • Inbound Health
  • Current Health
  • Rainbow Health
  • NTT Data
  • Virtua Health
  • SCP Health
  • Care.ai
  • CEVA Logistics
  • Dropoff
  • Cardinal Health
  • Tomorrow Health
  • Current Health
  • Biofourmis
  • Huma Health
  • Vivify Health
  • Locus Health
  • Health Recovery Solutions
  • BioIntelliSense
  • Cadence
  • Reimagine Care
  • WellSky
  • Datas Health
  • Vivalink
  • Medically Home
  • Dispatch Health
  • Conduit Health Partners
  • Contessa Health
  • Chartis
  • Inbound Health
  • Rainbow Health
  • CEVA Logistics
  • Dropoff
  • Cardinal Health
  • NTT Data
  • Huma Health
  • Current Health
  • Doccla
  • Biofourmis
  • WellSky
  • Datas Health
  • Contessa Health
  • Birdie
  • Cardinal Health
  • NTT Data
  • Vivalink
  • Telstra Health
  • CareMonitor
  • Contessa Health
  • Current Health
  • Biofourmis
  • Huma Health
  • WellSky
  • Cardinal Health
  • NTT Data
  • Vivalink

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Hospital-at-home Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Defining HaH

Market Segmentation

Market Segment Definitions

Segmentation by Geography

Common HaH Treatments

Key Competitors

Key Competitors (continued)

HaH Care Model—Patient Journey

HaH Care Steps—Patient Selection

HaH Care Steps—Patient Transfer

HaH Care Steps—Care Delivery

HaH Care Steps—Patient Discharge/Hospital Transfer

HaH Value Chain

Business Model Evolution: Home Healthcare to HaH

Major Provider Challenges with In-hospital Care

HaH as a Promising Alternative to In-hospital Care

Major Health Systems with HaH Models

Case Study: Mount Sinai

Consumer Readiness and Physician Perception of HaH

Regulatory and Reimbursement Policies

Regulatory and Reimbursement Policies (continued)

Challenges to HaH

Factors for Successful HaH Care

Recent Developments in HaH

Growth Metrics

Growth Drivers

Growth Restraints

Forecast Assumptions

Revenue Forecast

Revenue Forecast by Solution

Revenue Forecast Analysis

Revenue Forecast by Region

Global HaH Adoption: Key Examples

Revenue Forecast Analysis

Revenue Forecast Analysis (continued)

Pricing Trends and Forecast Analysis

The Future of HaH: Key Factors and Imperatives for Success

Competitive Environment

Revenue Share

Revenue Share Analysis

Competitive Overview

Competitive Overview (continued)

Key Company Profiles

Key Company Profiles (continued)

Key Company Profiles (continued)

Growth Metrics

Revenue Forecast

Revenue Forecast by Solution

Revenue Forecast by Region

Forecast Analysis

Growth Metrics

Revenue Forecast

Revenue Forecast by Solution

Revenue Forecast by Region

Forecast Analysis

Growth Opportunity 1: High Acuity and Chronic Care at Home

Growth Opportunity 1: High Acuity and Chronic Care at Home (continued)

Growth Opportunity 2: Integrated HaH Platforms with AI-powered Data Analytics

Growth Opportunity 2: Integrated HaH Platforms with AI-powered Data Analytics (continued)

Growth Opportunity 3: Advanced Automated Logistics Support 

Growth Opportunity 3: Advanced Automated Logistics Support (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

List of Exhibits (continued)

Legal Disclaimer

List of Figures
  • HaH: Solution Segmentation, Global, 2024
  • HaH: Commonly Treated Conditions, United States, 2023
  • Key Provider Challenges for In-hospital Care, Global, 2024
  • Health Systems with Implemented HaH Models, Global, 2024
  • HaH: Consumer Preferences, Global, 2024
  • HaH: Growth Metrics, Global, 2023
  • HaH Care Model: Growth Drivers, Global, 2024–2029
  • HaH Care Model: Growth Restraints, Global, 2024–2029
  • HaH: Revenue Forecast, Global, 2023–2029
  • HaH: Revenue Forecast by Solution, Global, 2023–2029
  • HaH: Revenue Forecast by Region, 2023–2029
  • HaH: Revenue Share of Top Participants, Global, 2023
  • HaH: Competitive Overview, Global, 2023
  • Technology Solutions: Growth Metrics, Global, 2023
  • Technology Solutions: Revenue Forecast, Global, 2023–2029
  • Technology Solutions: Revenue Forecast by Solution, Global, 2023–2029
  • Technology Solutions: Revenue Forecast by Region, Global, 2023–2029
  • Coordination Services: Growth Metrics, Global, 2023
  • Coordination Services: Revenue Forecast, Global, 2023–2029
  • Coordination Services: Revenue Forecast by Solution, Global, 2023–2029
  • Coordination Services: Revenue Forecast by Region, Global, 2023–2029

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-car...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The hospital-at-home (HaH) care model provides hospital-grade care in a home setting for acute patients with conditions ranging from asthma and pneumonia to congestive heart failure. This analysis will cover market size and forecast at the solution level, including technological solutions and care coordination services for acute care management HaH implementation. The geographic coverage is global, and the study period is from 2023 to 2029, while the forecast period extends from 2024 to 2029. Frost & Sullivan has identified three growth opportunities for industry stakeholders to seize. This business model promises to help hospitals and health systems in general overcome workforce shortages and capacity issues. Studies and evaluations demonstrate that the HaH s outcomes are equivalent to or on par with in-hospital care, garnering attention from all stakeholders. Other improvement parameters include reductions in costs, hospital readmission rates, risks of hospital-acquired infections, bed capacity, operational efficiency, and patient recovery time. HaH is, therefore, a viable alternative for healthcare players to provide quality care outside of the hospital setting. Author: Sagar Thamaji Mukhekar
More Information
Deliverable Type Market Research
Author Sagar Mukhekar
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Hospital-At-Home Market
Keyword 2 Forecast 2029 Hospital-At-Home
Keyword 3 Strategic Insights Hospital Services
List of Charts and Figures HaH: Solution Segmentation, Global, 2024~ HaH: Commonly Treated Conditions, United States, 2023~ Key Provider Challenges for In-hospital Care, Global, 2024~ Health Systems with Implemented HaH Models, Global, 2024~ HaH: Consumer Preferences, Global, 2024~ HaH: Growth Metrics, Global, 2023~ HaH Care Model: Growth Drivers, Global, 2024–2029~ HaH Care Model: Growth Restraints, Global, 2024–2029~ HaH: Revenue Forecast, Global, 2023–2029~ HaH: Revenue Forecast by Solution, Global, 2023–2029~ HaH: Revenue Forecast by Region, 2023–2029~ HaH: Revenue Share of Top Participants, Global, 2023~ HaH: Competitive Overview, Global, 2023~ Technology Solutions: Growth Metrics, Global, 2023~ Technology Solutions: Revenue Forecast, Global, 2023–2029~ Technology Solutions: Revenue Forecast by Solution, Global, 2023–2029~ Technology Solutions: Revenue Forecast by Region, Global, 2023–2029~ Coordination Services: Growth Metrics, Global, 2023~ Coordination Services: Revenue Forecast, Global, 2023–2029~ Coordination Services: Revenue Forecast by Solution, Global, 2023–2029~ Coordination Services: Revenue Forecast by Region, Global, 2023–2029~
Podcast No
Predecessor K5C4-01-00-00-00
WIP Number K9D0-01-00-00-00